C. diff. Spores and More

Welcome to Episode 3 of 6; of the 8th Annual Int'l C. diff. Post-Conference special series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual, collaborative events while focusing on Healthcare-associated infections (HAI), and the leading HAI -- Clostridioides difficile (Also known as C. diff.,

C. difficile, CDI, CDAD) with interconnected topics. In this episode, we will hear from three leading topic-experts:

Teena Chopra, MD, Introduction to Infection Prevention.

David Lyerly, Ph. D., Clostridioides difficile Infection; An Inflammatory Intestinal Disease.

Dale Gerding, MD, FACP, FIDSA, Non-toxigenic C. difficile Is Back,.

Presentation Slides are available until January 14th, 2021 on www.cdiff2020.com

We hope you enjoy the presentations from the leading topic-experts ,key note speakers of the 8th Annual Int'l C. diff. Conference & Health EXPO.

This audio broadcast is sponsored by Summit Therapeutics www.summitplc.com

Welcome to Episode 2 of 6; of the 8th Annual Int'l C. diff. Post-Conference Special series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual, collaborative events while focusing on Healthcare-associated infections (HAI), and the leading HAI -- Clostridioides difficile (Also known as C. diff., C. difficile, CDI, CDAD) with interconnected topics. In this episode, we will hear from two leading topic-experts and one C. diff. Survivor:

Dayle Skelly, C. diff. Survivor A Patient's Journey.

Dr. L. Clifford McDonald, MD: Update from the Center for Disease Control and Prevention.

Dr. Erik Dubberke, MD, MSPH: Optimizing Prevention of Hospital-Onset Clostridioides difficile.

Presentation Slides are available until January 14th, 2021

on www.cdiff2020.com

We hope you enjoy the presentations from

the 8th Annual Int'l C. diff. Conference & Health EXPO.

This audio broadcast is sponsored by Summit Therapeutics

www.summitplc.com

Welcome to Episode 1 of 6; 8th Annual Int'l C. diff. Post-Conference Special Series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual, collaborative event possessed while focusing on Healthcare-associated infections (HAI), and a leading HAI -- Clostridioides difficile (Also known as C. diff.,

C. difficile, CDI, CDAD) with interconnected topics. In this episode, we will hear from two leading topic-expert, and one C. diff. Survivor:

Dr. Paul Feuerstadt C. difficile Infection; Foundation For the Conference.

Mrs. Courtney Jones, Developing Next-Generation Microbioe-Based Therapeutics.

and

Alba Muhlfield, C. diff. Survivor ~ A Patient's Journey.

Presentation Slides are available until January 14th, 2021

on www.cdiff2020.com

We hope you enjoy the presentations from

the 8th Annual International C. diff. Conference & Health EXPO.

This audio broadcast is sponsored by Summit Therapeutics

www.summitplc.com

This episode of “C. diff. Spores and More” is focused on What is IBS? So you've been diagnosed with IBS (Irritable Bowel Sydrome). Now what? Join us for a discussion about the definition, diagnosis, and treatment of the various forms of IBS with our special guests: Dr. Caterina Oneto,, MD and Dr. Paul Feuerstadt, MD, Both professors and physicians specializing in Gastroenterology with a wealth of knowledge and experience treating patients diagnosed with a CDI and through ongoing scientific/medical research.

Join us with our guest: Mrs. Courtney Jones, Upstream Marketing Manager and Senior Project Manager at Rebiotix, a Ferring Pharmaceuticals company, focused on harnessing the power of the human microbiome to treat debilitating diseases.

Mrs. Jones will be discussing and explaining the Microbiome. What Microbes are and the difference between the good, bad, and in between and what the Microbiome has to do with C.diff. treatment.

There is a lot to learn about the science of the Microbiome and Mrs. Jones will certainly be educating us on this episode, Researching Bugs as Drugs to Fight C.diff..

Join us with our guests: Layla and Emma, members of a group of students, also known as the Golden Pandas, an FLL Robotics Team from Westfield, IN who has developed a special interest in helping to fight

C. diff. infections.

You can learn more this group of young researchers and reach out to the team on their

YouTube Channel:

https://www.youtube.com/watch?v=rKs_GiYjdN4

Join our guests

Andrew Rushworth and Mike Short as they discuss essential tools in an infection control program. Microfiber cloths and mops provide superior microbe and organic matter removal compared to traditional textiles but not all microfiber is created equal. Hear about what sets quality microfiber apart, the evidence behind it, and how it can serve as an effective infection prevention solution in healthcare.

Dr. David M. Lyerly, Ph. D., Chief Science Officer, TechLab, Inc.

will be joining us to discuss C. difficile Infections (CDI) and Secondary Bacterial Pneumonia. Dr. Lyerly will lead us off in an overview of viral respiratory infections and how they can lead to secondary bacterial pneumonia. As a result, antibiotics often are given empirically to prevent these types of secondary infections. Treatment with antibiotics, although justified in the treatment of bacterial pneumonia, is a primary predisposing factor in the onset of C. difficile infections (CDI). This discussion will provide a background on CDI and secondary bacterial pneumonia. The discussion will also include the relationship between viral and bacterial pneumonia, and how they relate to the onset of a CDI. In addition, the challenge of accurately identifying COVID-19 and FLU season will be discussed. Concluding remarks will focus on why antibiotic stewardship remains especially critical during this global pandemic.

Join us with our guest

James Boone, M.S., as we discuss

Inflammatory Bowel Disease patients who are highly susceptible to

C. difficile infections. The two diseases have similar symptoms, but very different treatments. This segment will examine the diagnostic methods which can distinguish between inflammatory bowel disease and C. difficile infection, discuss testing guidelines, and touch upon recent clinical research and advances.

Join us with Guest; Doe Kley, RN, CIC, MPH,T-CHEST

Senior Infection Preventionist with

Clorox Professional Products Co.

Ms. Kley will be discussing the importance of knowing the key-points in transitioning from an acute-care facility, long-term facility, and intermediate healthcare facility to the home environment.